BRIEF published on 03/16/2026 at 10:40, 6 months 14 days ago Piramal Pharma Solutions Achieves 1,500th ADC Batch Milestone Pharmaceutical Development Piramal Pharma Grangemouth Facility ADC Manufacturing Bioconjugate Therapies
PRESS RELEASE published on 03/16/2026 at 10:35, 6 months 14 days ago Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch Piramal Pharma Solutions' Grangemouth, UK Facility achieves 1,500th ADC batch milestone, showcasing advanced capabilities and commitment to bioconjugate therapies CDMO Piramal Pharma Solutions Grangemouth Bioconjugate Therapies ADC Batch
BRIEF published on 02/02/2026 at 17:15, 7 months 28 days ago Piramal Pharma Solutions Unveils Tablet-in-Capsule Technology Drug Delivery Piramal Pharma Tablet-in-Capsule Patient Centricity Customized Dosing
PRESS RELEASE published on 02/02/2026 at 17:10, 7 months 28 days ago Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities Piramal Pharma Solutions successfully develops tablet-in-capsule drug delivery system, offering flexible dosing options for oral therapies. Enhancing patient-centric solutions Drug Delivery System Patient-centric Piramal Pharma Solutions Tablet-in-Capsule Flexible Dosing Options
BRIEF published on 12/15/2025 at 07:10, 9 months 15 days ago Piramal Pharma Solutions Achieves High Net Promoter Score Operational Excellence Net Promoter Score Customer Loyalty Piramal Pharma Competitive Positioning
PRESS RELEASE published on 12/15/2025 at 07:05, 9 months 15 days ago Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score Piramal Pharma Solutions achieves impressive Net Promoter Score (NPS) of 55, surpassing industry averages, reflecting commitment to excellence and stakeholder centricity Operational Excellence Net Promoter Score Piramal Pharma Solutions NPS Stakeholder Centricity
BRIEF published on 11/26/2025 at 20:30, 10 months 3 days ago Piramal Pharma Solutions Ensures Compliance with Nitrosamine Regulations Regulatory Standards Piramal Pharma Solutions Nitrosamine Compliance Pharmaceutical Safety Testing Capabilities
PRESS RELEASE published on 11/26/2025 at 20:25, 10 months 3 days ago Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities Piramal Pharma Solutions achieves regulatory compliance for nitrosamine impurities, ensuring safety & adherence to global guidelines, enhancing capabilities & operational excellence Regulatory Compliance Operational Excellence Patient Safety Piramal Pharma Solutions Nitrosamine Impurities
BRIEF published on 11/19/2025 at 09:00, 10 months 11 days ago Piramal Pharma's Grangemouth Facility Secures Updated MHRA GMP Certifications ADC Development GMP Certification MHRA Approval Piramal Pharma Grangemouth Facility
PRESS RELEASE published on 11/19/2025 at 08:55, 10 months 11 days ago Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK receives updated MHRA GMP certificates, highlighting commitment to quality and regulatory excellence Drug Development Piramal Pharma Solutions Bioconjugates Facility MHRA GMP Certificates Grangemouth
Published on 09/30/2026 at 15:50, 4 hours 6 minutes ago Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans
Published on 09/30/2026 at 14:37, 5 hours 19 minutes ago NuRAN Leverages Starlink Backhaul to Drive Higher Revenue Per Rural Site
Published on 09/30/2026 at 14:31, 5 hours 25 minutes ago First Breach Expands Ammunition Manufacturing Operations to Seven Days a Week
Published on 09/30/2026 at 14:07, 5 hours 49 minutes ago Worksport COR Energy System Now Available Through Amazon
Published on 09/30/2026 at 13:30, 6 hours 26 minutes ago Nextech3D.ai Engages MZ Group to Lead Strategic Investor Relations Program
Published on 09/30/2026 at 18:39, 1 hour 16 minutes ago Advanced Blockchain AG Publishes 2026 Half-Year Report and Advances ABAG 2.0 Strategy
Published on 09/30/2026 at 18:26, 1 hour 29 minutes ago Kaufman & Broad SA: RESULTS FOR THE FIRST NINE MONTHS OF 2026
Published on 09/30/2026 at 18:12, 1 hour 44 minutes ago BOOSTER Precision Components Holding announces prolongation of standstill agreement with Ad-hoc Group
Published on 09/30/2026 at 18:00, 1 hour 55 minutes ago Shaping Tradition with Technology: An American Artist’s Ceramic Journey in China
Published on 09/30/2026 at 18:44, 1 hour 11 minutes ago Broadcast of the 5th edition of “On the way up”
Published on 09/30/2026 at 18:15, 1 hour 41 minutes ago The Belgian State and ENGIE Group have agreed to extend the target date for concluding the Heads of Terms until 4 november 2026
Published on 09/30/2026 at 18:00, 1 hour 56 minutes ago Thales announces the distribution of an interim dividend
Published on 09/30/2026 at 18:00, 1 hour 56 minutes ago Cie du Bois Sauvage : Compagnie du Bois Sauvage increases its stake in Eaglestone to support its long-term development (Inside information)
Published on 09/30/2026 at 12:00, 7 hours 56 minutes ago Capital increase through exercise of subscription rights
